Therapeutic efficacy of cabozantinib for hepatocellular carcinoma

Cabozantinib and mTOR inhibitors may represent a novel therapeutic approach for hepatocellular carcinoma.
Cabozantinib and mTOR inhibitors may represent a novel therapeutic approach for hepatocellular carcinoma.